Literature DB >> 2828662

Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18.

D Gius1, S Grossman, M A Bedell, L A Laimins.   

Abstract

The noncoding region of human papillomavirus type 18 (HPV-18) is shown to contain at least three enhancer elements. Two of these elements are responsive to papillomavirus-encoded trans-acting factors, and the third element functions as a constitutive enhancer, requiring only cellular factors for activity. The first enhancer (IE2) is located proximal to the E6 cap site and is responsive to papillomavirus E2 trans-activator. The second enhancer (IE6) is located approximately 500 base pairs upstream of the E6 cap site and is dependent upon the viral E6 gene product for function. A third enhancer (C) is located between 200 and 400 base pairs upstream of the E6 cap site and possesses a constitutive activity, requiring no HPV-18-encoded factors for function. The constitutive enhancer element exhibits some cell type preference for epithelial cell lines, but also functions in rodent fibroblast lines. Each of these enhancers manifests activity independent of the other elements and may reflect separate transcriptional control elements for different stages of the HPV-18 virus life cycle.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828662      PMCID: PMC253618          DOI: 10.1128/JVI.62.3.665-672.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat-1 cells.

Authors:  M A Bedell; K H Jones; L A Laimins
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix.

Authors:  M M Pater; A Pater
Journal:  Virology       Date:  1985-09       Impact factor: 3.616

3.  Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product.

Authors:  B A Spalholz; Y C Yang; P M Howley
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

4.  Genital papillomavirus infections.

Authors:  H zur Hausen
Journal:  Prog Med Virol       Date:  1985

5.  A new small (40 kd) keratin filament protein made by some cultured human squamous cell carcinomas.

Authors:  Y J Wu; J G Rheinwald
Journal:  Cell       Date:  1981-09       Impact factor: 41.582

6.  Polyoma virus DNA replication requires an enhancer.

Authors:  J de Villiers; W Schaffner; C Tyndall; S Lupton; R Kamen
Journal:  Nature       Date:  1984 Nov 15-21       Impact factor: 49.962

7.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells.

Authors:  E Schwarz; U K Freese; L Gissmann; W Mayer; B Roggenbuck; A Stremlau; H zur Hausen
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  Characterization of the bovine papilloma virus plasmid maintenance sequences.

Authors:  M Lusky; M R Botchan
Journal:  Cell       Date:  1984-02       Impact factor: 41.582

10.  A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer.

Authors:  M Boshart; L Gissmann; H Ikenberg; A Kleinheinz; W Scheurlen; H zur Hausen
Journal:  EMBO J       Date:  1984-05       Impact factor: 11.598

View more
  47 in total

Review 1.  Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.

Authors:  Oishee Chakrabarti; Sudhir Krishna
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

2.  Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes.

Authors:  M Hummel; J B Hudson; L A Laimins
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes.

Authors:  F Thierry; G Spyrou; M Yaniv; P Howley
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

4.  Delineation of human papillomavirus type 18 enhancer binding proteins: the intracellular distribution of a novel octamer binding protein p92 is cell cycle regulated.

Authors:  H D Royer; M P Freyaldenhoven; I Napierski; D D Spitkovsky; T Bauknecht; N Dathan
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

5.  Cooperative binding of the E2 protein of bovine papillomavirus to adjacent E2-responsive sequences.

Authors:  P Monini; S R Grossman; B Pepinsky; E J Androphy; L A Laimins
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

6.  CCAAT displacement protein, a regulator of differentiation-specific gene expression, binds a negative regulatory element within the 5' end of the human papillomavirus type 6 long control region.

Authors:  S Pattison; D G Skalnik; A Roman
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  Cooperative activation of transcription by bovine papillomavirus type 1 E2 can occur over a large distance.

Authors:  F Thierry; N Dostatni; F Arnos; M Yaniv
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

8.  Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18.

Authors:  J B Hudson; M A Bedell; D J McCance; L A Laiminis
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

9.  Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation.

Authors:  M T Chin; T R Broker; L T Chow
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

10.  The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells.

Authors:  C L Halbert; G W Demers; D A Galloway
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.